FDA
approval
· 2024-07-26
FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Sandoz Inc)
Summary
The FDA approved Sandoz Inc's original generic application for lisdexamfetamine dimesylate, authorizing its use as a stimulant medication. The product is intend…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)